Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,692.00
Bid: 2,686.00
Ask: 2,688.00
Change: -14.00 (-0.52%)
Spread: 2.00 (0.074%)
Open: 2,708.00
High: 2,708.00
Low: 2,670.00
Prev. Close: 2,706.00
CCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Regulatory Announcement

29 Apr 2013 10:17

RNS Number : 4537D
Coca-Cola HBC AG
29 April 2013
 



FOR IMMEDIATE RELEASE

Coca-Cola HBC AG

 

Regulatory Announcement

 

 

Zug, Switzerland - 29 April 2013 - Further to its announcement of earlier today in connection with the admission of its ordinary shares to the premium listing segment of the Official List of the United Kingdom Listing Authority and to trading on the main market for listed securities of the London Stock Exchange ("Admission"), under the ticker CCH, Coca-Cola HBC AG ("Coca-Cola HBC") hereby announces the following:

Share Capital Information and Total Voting Rights

On Admission, Coca-Cola HBC's issued share capital consisted of 355,023,939 ordinary shares of CHF 6.70, of which 14,925 ordinary shares are held by Coca-Cola HBC in treasury. Accordingly, as at today's date, the total number of voting rights in Coca-Cola HBC is 355,009,014 for the purposes of the Disclosure and Transparency Rules of the Financial Conduct Authority ("DTRs").

Shareholders may use the above total voting rights figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of Coca-Cola HBC under the DTRs.

This announcement is made in accordance with DTR 5.6.1.

Board of Directors and Composition of Board committees

On 25 April 2013, out of the seven members of the board of directors (the "Board") of Coca-Cola HBC three members resigned, namely Mr. Patrick Oesch, Mr. Ryan Rudolph and Ms. Claudia Goebel. Upon such resignations, nine new directors were appointed to the Board of Coca-Cola HBC in addition to the remaining fourdirectors. As a result of these changes, the Board of Coca-Cola HBC comprises 13 directors, as follows:

George A. David

Chairman

Anastasios P. Leventis

Vice-chairman

Anastassis G. David

Non-executive director

Haralambos K. Leventis

Non-executive director

Dimitris Lois

Executive director

John Hunter

Non-executive director

Irial Finan

Non-executive director

Sir Michael Llewellyn-Smith

Independent non-executive director

Nigel Macdonald

Independent non-executive director

Antonio D'Amato

Independent non-executive director

Kent Atkinson

Senior Independent non-executive director

Christos Ioannou

Independent non-executive director

Susan Kilsby

Independent non-executive director

 

As of the same date, the Board of Coca-Cola HBC constituted the following committees:

Audit committee: Mr. Kent Atkinson (chairman), Mr. Christos Ioannou and Mr. Nigel Macdonald.

Nomination committee: Sir Michael Llewellyn-Smith (chairman), Mr. Anastassis G. David, Mr. Antonio D'Amato, Mrs. Susan Kilsby and Mr. John Hunter.

Remuneration committee: Sir Michael Llewellyn-Smith (chairman), Mr. Antonio D'Amato and Mrs. Susan Kilsby.

Social Responsibility committee: Sir Michael Llewellyn-Smith (chairman), Mr. George A. David and Mr. John Hunter.

Home Member State Notification

Coca-Cola HBC hereby elects the United Kingdom as its Home Member State for the purposes of the EU Transparency Directive (2004/109/EC, as amended).

 

 

Enquiries

 

Coca‑Cola Hellenic Group

 

Oya Gur

Investor Relations Director

Tel: +30 210 618 3255

email: oya.gur@cchellenic.com

 

Panagiotis Vergis

Investor Relations Manager

Tel: +30 210 618 3124

email: panagiotis.vergis@cchellenic.com

 

Eri Tziveli

Investor Relations Manager

Tel: +30 210 618 3133

email: eri.tziveli@cchellenic.com

 

Corporate brokers:

 

Credit Suisse

George Maddison

Tristan Lovegrove

Tel: +44 20 7888 8888

 

email: george.maddison@credit-suisse.com

email: tristan.lovegrove@credit-suisse.com

 

J.P. Morgan Cazenove

 

Laurence Hollingworth

James Mitford

Tel: +44 20 7251 3801

 

email: laurence.hollingworth@jpmorgancazenove.com

email: james.mitford@jpmorgancazenove.com

 

International media contact:

 

RLM Finsbury

 

Guy Lamming

Charles Chichester

 

Tel: +44 20 7251 3801

 

email: guy.lamming@rlmfinsbury.com

email: charles.chichester@rlmfinsbury.com 

Greek media contact:

 

V+O Communications

Mary Andreadi

Tel: +30 211 7501223

email: ma@vando.gr

 

 

About Coca‑Cola HBC AG

Coca‑Cola HBC is the second-largest bottler of products of The Coca‑Cola Company in terms of volume with sales of more than 2 billion unit cases. It has a broad geographic footprint with operations in 28 countries serving a population of approximately 581 million people. Coca‑Cola HBC offers a diverse range of ready-to-drink non-alcoholic beverages in the sparkling, juice, water, sport, energy, tea and coffee categories. Coca‑Cola HBC is committed to promoting sustainable development in order to create value for its business and for society. This includes providing products that meet the beverage needs of consumers, fostering an open and inclusive work environment, conducting our business in ways that protect and preserve the environment and contribute to the socio-economic development of our local communities.

Coca‑Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and its shares are listed on the Athens Exchange (ATHEX: EEE). Coca‑Cola HBC's American Depositary Receipts (ADRs) are listed on the New York Stock Exchange (NYSE: CCH). Coca‑Cola HBC is included in the Dow Jones Sustainability and FTSE4Good Indexes. For more information, please visit http://www.coca‑colahellenic.com/.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEANLNAFSDEEF
Date   Source Headline
14th Jun 20245:11 pmRNSTransaction in Own Shares
14th Jun 20247:09 amRNSTransaction in Own Shares
11th Jun 20245:41 pmRNSTransaction in Own Shares
10th Jun 20245:25 pmRNSTransaction in Own Shares
5th Jun 20245:32 pmRNSTransaction in Own Shares
4th Jun 20245:28 pmRNSTransaction in Own Shares
3rd Jun 20245:19 pmRNSTransaction in Own Shares
3rd Jun 20244:11 pmRNSIssue of Equity and total voting rights
31st May 20245:25 pmRNSTransaction in Own Shares
30th May 20245:36 pmRNSTransaction in Own Shares
29th May 20243:25 pmRNSDirector/PDMR Shareholding
29th May 20243:19 pmRNSDirector/PDMR Shareholding
28th May 202410:07 amRNSDirector/PDMR Shareholding
28th May 202410:04 amRNSDirector/PDMR Shareholding
22nd May 20245:43 pmRNSDirector/PDMR Shareholding
21st May 20246:01 pmRNSComposition of the Board Committees
21st May 20245:55 pmRNSResult of AGM
20th May 20244:44 pmRNSDirector/PDMR Shareholding
15th May 20244:19 pmRNSDirector/PDMR Shareholding
13th May 202411:30 amRNSDirector/PDMR Shareholding
8th May 20245:50 pmRNSTransaction in Own Shares
7th May 20245:29 pmRNSTransaction in Own Shares
3rd May 20245:25 pmRNSTransaction in Own Shares
3rd May 202412:46 pmRNSDirector/PDMR Shareholding
3rd May 202412:38 pmRNSDirector/PDMR Shareholding
2nd May 20245:41 pmRNSTransaction in Own Shares
2nd May 202412:40 pmRNSAthens Exchange trading date of ordinary shares
1st May 20245:47 pmRNSTransaction in Own Shares
1st May 202410:09 amRNSBlock listing Interim Review
1st May 20249:10 amRNSIssue of equity and total voting rights
30th Apr 20247:00 amRNSStrong start; reiterating 2024 guidance
19th Apr 20249:20 amRNSNotice of AGM
18th Apr 20244:21 pmRNSDirector/PDMR Shareholding
5th Apr 20242:17 pmRNSNotice of Results
2nd Apr 202411:12 amRNSIssue of equity and total voting rights
28th Mar 20245:55 pmRNSDirector/PDMR Shareholding
28th Mar 20245:47 pmRNSDirector/PDMR Shareholding
28th Mar 20245:42 pmRNSDirector/PDMR Shareholding
28th Mar 20245:26 pmRNSTransaction in Own Shares
27th Mar 20245:23 pmRNSTransaction in Own Shares
26th Mar 20245:05 pmRNSTransaction in Own Shares
26th Mar 20249:09 amRNSDirector/PDMR Shareholding
25th Mar 20245:10 pmRNSTransaction in Own Shares
22nd Mar 20245:27 pmRNSTransaction in Own Shares - Replacement
22nd Mar 20245:05 pmRNSTransaction in Own Shares
21st Mar 20245:40 pmRNSTransaction in Own Shares
20th Mar 20245:33 pmRNSTransaction in Own Shares
19th Mar 20245:20 pmRNSTransaction in Own Shares
19th Mar 20241:19 pmRNSDirector/PDMR Shareholding
18th Mar 20245:20 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.